Biohacker Wants To Make A Genetic Upgrade To Dalmatians—But The FDA Isn't On Board Just Yet
David Ishee is a Mississippi kennel operator with a passion for dogs and a plan to improve them using a gene-editing technology called CRISPR from a modest laboratory he’s built in a plywood shed.
Sound unlikely? It’s serious enough that the U.S. Food and Drug Administration, in a phone call last week, told Ishee he wouldn’t be able to sell any edited dogs without its approval.
Sound unlikely? It’s serious enough that the U.S. Food and Drug Administration, in a phone call last week, told Ishee he wouldn’t be able to sell any edited dogs without its approval.